Padagis Israel Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PADAGIS ISRAEL, and what generic and branded alternatives to PADAGIS ISRAEL drugs are available?
PADAGIS ISRAEL has eighty-one approved drugs.
Summary for Padagis Israel
| US Patents: | 0 |
| Tradenames: | 49 |
| Ingredients: | 49 |
| NDAs: | 81 |
| Patent Litigation for Padagis Israel: | See patent lawsuits for Padagis Israel |
Drugs and US Patents for Padagis Israel
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Israel | AMMONIUM LACTATE | ammonium lactate | CREAM;TOPICAL | 075774-001 | May 1, 2002 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Padagis Israel | CYANOCOBALAMIN | cyanocobalamin | SPRAY, METERED;NASAL | 212458-001 | Sep 9, 2020 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Padagis Israel | TAZAROTENE | tazarotene | GEL;TOPICAL | 213079-002 | Apr 25, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Padagis Israel | CICLOPIROX | ciclopirox | SUSPENSION;TOPICAL | 077676-001 | Dec 15, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Padagis Israel | TAZAROTENE | tazarotene | GEL;TOPICAL | 213079-001 | Apr 25, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for PADAGIS ISRAEL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Vaginal Cream | 2% | ➤ Subscribe | 2009-12-23 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
